Today's Pre-Market Movers and Top Ratings | SANA, PANW, ADBE and More

$Sana Biotechnology (SANA.US)$ saw its shares skyrocket by 260% following the announcement of positive results from a study involving its allogeneic primary islet cell therapy, UP421. The therapy was successfully tested on a type 1 diabetes patient without the need for immunosuppression.

$Absci Corp (ABSI.US)$ shares surged 57% after the company announced a collaboration with $Advanced Micro Devices (AMD.US)$ to accelerate advancements in AI-driven drug discovery.

$Cal-Maine Foods (CALM.US)$ shares climbed more than 4% following the release of its better-than-expected FQ2 results. The strong performance was attributed to higher egg prices, robust holiday demand, a 12.8% drop in feed costs, and an 8.5% reduction in production expenses.

$Palo Alto Networks (PANW.US)$ shares dropped 2.7% after receiving downgrades from analysts at BTIG and Deutsche Bank. BTIG highlighted concerns about the company's growth potential in its core network security segment and its Next-Generation Security business.

$Adobe (ADBE.US)$ shares declined 1.3% after Deutsche Bank downgraded the stock from "buy" to "hold," citing the need for "more tangible evidence" of the company's ability to monetize its artificial intelligence offerings.